selzentry

Generic: maraviroc

Labeler: viiv healthcare company
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name selzentry
Generic Name maraviroc
Labeler viiv healthcare company
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

maraviroc 150 mg/1

Manufacturer
ViiV Healthcare Company

Identifiers & Regulatory

Product NDC 49702-223
Product ID 49702-223_c3a27122-8cd6-4889-a1ef-7ef629c270b3
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA022128
Listing Expiration 2026-12-31
Marketing Start 2011-05-16

Pharmacologic Class

Established (EPC)
ccr5 co-receptor antagonist [epc]
Mechanism of Action
chemokine co-receptor 5 antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 49702223
Hyphenated Format 49702-223

Supplemental Identifiers

RxCUI
728223 728225 729201 729203 1857921 1857925
UNII
MD6P741W8A
NUI
N0000175572 N0000175445

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name selzentry (source: ndc)
Generic Name maraviroc (source: ndc)
Application Number NDA022128 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 60 TABLET, FILM COATED in 1 BOTTLE (49702-223-18)
source: ndc

Packages (1)

49702-223-18 60 TABLET, FILM COATED in 1 BOTTLE (49702-223-18)

Ingredients (1)

maraviroc (150 mg/1)

Linked Drug Pages (1)

SELZENTRY ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "c3a27122-8cd6-4889-a1ef-7ef629c270b3", "openfda": {"nui": ["N0000175572", "N0000175445"], "unii": ["MD6P741W8A"], "rxcui": ["728223", "728225", "729201", "729203", "1857921", "1857925"], "spl_set_id": ["46f30ac5-c96b-429e-976d-8c5ee1c0761b"], "pharm_class_epc": ["CCR5 Co-receptor Antagonist [EPC]"], "pharm_class_moa": ["Chemokine Co-receptor 5 Antagonists [MoA]"], "manufacturer_name": ["ViiV Healthcare Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (49702-223-18)", "package_ndc": "49702-223-18", "marketing_start_date": "20110516"}], "brand_name": "SELZENTRY", "product_id": "49702-223_c3a27122-8cd6-4889-a1ef-7ef629c270b3", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["CCR5 Co-receptor Antagonist [EPC]", "Chemokine Co-receptor 5 Antagonists [MoA]"], "product_ndc": "49702-223", "generic_name": "maraviroc", "labeler_name": "ViiV Healthcare Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "SELZENTRY", "active_ingredients": [{"name": "MARAVIROC", "strength": "150 mg/1"}], "application_number": "NDA022128", "marketing_category": "NDA", "marketing_start_date": "20110516", "listing_expiration_date": "20261231"}